Anthony LaPlaca - Apr 1, 2022 Form 4 Insider Report for INVACARE CORP (IVC)

Role: Sr. VP and General Counsel
Signature: /s/ Anthony C. LaPlaca, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney, dated December 30, 2008, on file with the Commission
Stock symbol: IVC
Transactions as of: Apr 1, 2022
Transactions value $: $0
Form type: 4
Date filed: 4/5/2022, 04:51 PM
Previous filing: Mar 14, 2022
Next filing: May 17, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IVC	Common Shares	Award	$0	+20.9K	+21.2%	$0.00	119K	Apr 1, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	IVC	Employee Stock Option (Right to Buy)						71.9K	Apr 1, 2022	Common Shares	71.9K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted shares granted pursuant to the Invacare Corporation 2018 Equity Compensation Plan in an exempt transaction under Rule 16b-3. These shares vest in 1/3 annual increments over three years commencing on May 15, 2023.
F2	No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
F3	The reporting person holds previously reported options to buy 71,933 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan and the Invacare Corporation 2013 Equity Compensation Plan, granted in reliance upon the exemption provided by Rule 16b-3. These options were granted between August 14, 2012 and March 16, 2017, at exercise prices between $12.15 to $14.49 per share, will expire between August 14, 2022 and March 16, 2027, and became exercisable between September 30, 2013 and February 19, 2020.